Global Contraceptive Devices Market 2015-2019

Global Contraceptive Devices Market 2015-2019

Category : Medical Devices
Published On : July  2015
Pages : 91



TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com
About Contraception Devices

Contraception methods can be temporary or permanent and are available for both men and women. Permanent methods include sterilization for women (tubal occlusion or hysteroscopy) and sterilization for men (vasectomy) . Temporary methods are hormonal and non-hormonal. Hormonal methods include contraceptive transdermal patches, oral contraceptive pills, hormonal IUDs, vaginal rings, and vaginal implants. Non-hormonal methods include withdrawal methods, diaphragms, condoms, sponges, cervical caps, and non-hormonal IUDs. Condoms, diaphragms, sponges, and cervical caps are also referred to as barrier contraception methods. 

Technavio's analysts forecast the global contraceptive devices market to grow at a CAGR of 4.88% over the period 2014-2019. 

Covered in this Report

The report includes the present scenario and the growth prospects of the global contraceptive devices market for the period 2015-2019. To calculate the market size, we considered revenue generated from sales of various contraception devices.

Technavio's report, Global Contraceptive Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global contraceptive devices market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions 
• Americas
• EMEA
• APAC

Key Vendors
• Ansell 
• Actavis 
• Bayer
• Church & Dwight
• Merck & Co 

Other Prominent Vendor
• Agile Therapeutics
• Caya 
• Condomi Health International
• Fuji Latex
• HLL Lifecare
• Karex Industries
• Lipocine
• Mayer Laboratories 
• Medicines 360
• Okamoto Industries
• Reckitt Benckiser Group
• Teva Pharmaceuticals
• The Female Health Company
• TodaySponge

Market Driver
• Growing Prevalence of Unplanned Pregnancies 
• For a full, detailed list, view our report

Market Challenge
• Threat of Low-Cost Generic Contraceptives
• For a full, detailed list, view our report

Market Trend
• Increasing Strategic Partnerships
• For a full, detailed list, view our report

Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Types of Contraceptive Methods
07. Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Five Forces Analysis
08. Market Segmentation by Product Type
09. Global Condoms Market
09.1 Market Size and Forecast
10. Global IUDs Market
10.1 Market Size and Forecast
11. Global Subdermal Contraceptive Implants Market
11.1 Market Size and Forecast
12. Global Vaginal Rings Market
12.1 Market Size and Forecast
13. Global Non-surgical Permanent Contraception Devices Market
13.1 Market Size and Forecast
14. Global Contraceptive Diaphragms Market
14.1 Market Size and Forecast
15. Global Contraceptive Sponges Market
15.1 Market Size and Forecast
16. Geographical Segmentation
16.1 Contraceptive Devices Market in Americas
16.1.1 Market Size and Forecast
16.2 Contraceptive Devices Market in EMEA
16.2.1 Market Size and Forecast
16.3 Contraceptive Devices Market in APAC
16.3.1 Market Size and Forecast
17. Buying Criteria
18. Market Growth Drivers
19. Drivers and Their Impact
20. Market Challenges
21. Impact of Drivers and Challenges
22. Market Trends
23. Trends and Their Impact
24. Vendor Landscape
24.1 Competitive Scenario
24.1.1 Key News
24.1.2 Mergers and Acquisitions
24.2 Market Share Analysis 2014
24.2.1 Actavis
24.2.2 Ansell
24.2.3 Bayer
24.2.4 Church & Dwight
24.2.5 Merck
24.3 Other Prominent Vendors
25. Key Vendor Analysis
25.1 Actavis
25.1.1 Key Facts
25.1.2 Business Overview
25.1.3 Business Segmentation
25.1.4 Business Segmentation by Revenue 2012 and 2013
25.1.5 Geographical Segmentation by Sales 2013
25.1.6 Business Strategy
25.1.7 Recent Developments
25.1.8 SWOT Analysis
25.2 Ansell
25.2.1 Key Facts
25.2.2 Business Overview
25.2.3 Business Segmentation by Revenue 2014
25.2.4 Business Segmentation by Revenue 2013 and 2014
25.2.5 Geographical Segmentation by Revenue 2014
25.2.6 Recent Developments
25.2.7 SWOT Analysis
25.3 Bayer
25.3.1 Key Facts
25.3.2 Business Overview
25.3.3 Business Segmentation by Revenue 2014
25.3.4 Business Segmentation by Revenue 2013 and 2014
25.3.5 Geographical Segmentation by Revenue 2014
25.3.6 Business Strategy
25.3.7 Recent Developments
25.3.8 SWOT Analysis
25.4 Church & Dwight
25.4.1 Key Facts
25.4.2 Business Overview
25.4.3 Business Segmentation by Revenue 2013
25.4.4 Business Segmentation by Revenue 2012 and 2013
25.4.5 Geographical Segmentation by Revenue 2013
25.4.6 Business Strategy
25.4.7 Recent Developments
25.4.8 SWOT Analysis
25.5 Merck
25.5.1 Key Facts
25.5.2 Business Overview
25.5.3 Business Segmentation by Revenue 2013
25.5.4 Business Segmentation by Revenue 2012 and 2013
25.5.5 Sales by Geography
25.5.6 Business Strategy
25.5.7 Key Developments
25.5.8 SWOT Analysis
26. Other Reports in This Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Market Overview
Exhibit 3: Global Contraceptive Devices Market 2014-2019 ($ millions)
Exhibit 4: Segmentation of Global Contraceptive Devices Market by Product Type
Exhibit 5: Segmentation of Global Contraceptive Devices Market by Product Type 2014
Exhibit 6: Global Condoms Market 2014-2019 ($ millions)
Exhibit 7: Global IUDs Market 2014-2019 ($ millions)
Exhibit 8: Global Subdermal Contraceptive Implants Market 2014-2019 ($ millions)
Exhibit 9: Global Vaginal Rings Market 2014-2019 ($ millions)
Exhibit 10: Global Non-surgical Permanent Contraception Devices Market 2014-2019 ($ millions)
Exhibit 11: Global Contraceptive Diaphragms Market 2014-2019 ($ millions)
Exhibit 12: Global Contraceptive Sponges Market 2014-2019 ($ millions)
Exhibit 13: Segmentation of Global Contraceptive Devices Market by Product Type 2014-2019 ($ millions)
Exhibit 14: Segmentation of Global Contraceptive Devices Market by Product Type 2014-2019
Exhibit 15: Segmentation of Global Contraceptive Devices Market by Geography 2014
Exhibit 16: Contraceptive Devices Market in Americas 2014-2019 ($ millions)
Exhibit 17: Contraceptive Devices Market in EMEA 2014-2019 ($ millions)
Exhibit 18: Contraceptive Devices Market in APAC 2014-2019 ($ millions)
Exhibit 19: Segmentation of Global Contraceptive Devices Market by Geography 2014-2019 ($ millions)
Exhibit 20: Segmentation of Global Contraceptive Devices Market by Geography 2014-2019
Exhibit 21: Major Drivers of Global Contraceptive Devices Market
Exhibit 22: STDs in US
Exhibit 23: Estimated Cases of STIs in US
Exhibit 24: Total Population Growth Rate and Crude Birthrate 2007-2012
Exhibit 25: Major Challenges in Global Contraceptive Devices Market
Exhibit 26: Major Trends in Global Contraceptive Devices Market
Exhibit 27: Global Fertility Rate 2007-2012
Exhibit 28: Actavis: Key Takeaways
Exhibit 29: Ansell: Key Takeaways
Exhibit 30: Bayer: Key Takeaways
Exhibit 31: Church & Dwight: Key Takeaways
Exhibit 32: Merck: Key Takeaways
Exhibit 33: Actavis: Business Segmentation
Exhibit 34: Actavis: Business Segmentation by Revenue 2012 and 2013 ($ millions)
Exhibit 35: Actavis: Geographical Segmentation by Sales 2013
Exhibit 36: Ansell: Business Segmentation by Revenue 2014
Exhibit 37: Ansell: Business Segmentation by Revenue 2013 and 2014 ($ millions)
Exhibit 38: Ansell: Geographical Segmentation by Revenue 2014
Exhibit 39: Bayer: Business Segmentation by Revenue 2014
Exhibit 40: Bayer: Business Segmentation by Revenue 2013 and 2014 ($ billions)
Exhibit 41: Bayer: Geographical Segmentation by Revenue 2014
Exhibit 42: Church & Dwight: Business Segmentation by Revenue 2013
Exhibit 43: Church & Dwight: Business Segmentation by Revenue 2012 and 2013 ($ billions)
Exhibit 44: Church & Dwight: Geographical Segmentation by Revenue 2013
Exhibit 45: Merck: Business Segmentation by Revenue 2013
Exhibit 46: Merck: Business Segmentation by Revenue 2012 and 2013 ($ billions)
Exhibit 47: Merck: Sales by Geography 2013

Enquiry Before Buy
image
Can´t read the image ? refresh here.